Sohn S, Schöffski O, Prinz JC, Reich K, Waldorf K, Augustin M (2006)
Publication Type: Journal article
Publication year: 2006
Book Volume: 212
Pages Range: 137-144
DOI: 10.1159/000090654
Background: There is little information concerning the costs of psoriasis and patients’ quality of life (QoL) in Germany. Objective: To obtain data on the annual costs and QoL(to follow in a further publication) of patients with moderate to severe plaque psoriasis. Methods: Between October 2003 and February 2004, six office-based dermatologists and eight dermatology outpatient departments retrospectively documented cost-of-illness data from a societal cost perspective in 184 patients over a 12-month period. Patients were stratified into three subgroups according to their treatment scheme. Results: Mean total costs amounted to € 6,709 per patient and year. The mean PASI score was 18.2 and PBSA 28.9%. Annual costs were highest with € 8,831 in high-need patients. They also showed the highest PASI score (22.2). Conclusion: Moderate to severe plaque psoriasis is associated with tremendous costs, particularly in patients not adequately controlled by conventional therapies, while the outcomes of patients were unsatisfactory.
APA:
Sohn, S., Schöffski, O., Prinz, J.C., Reich, K., Waldorf, K., & Augustin, M. (2006). Cost of Moderate to Severe Plaque Psoriasis in Germany: A Multicenter Cost-of-Illness Study. Journal der Deutschen Dermatologischen Gesellschaft, 212, 137-144. https://doi.org/10.1159/000090654
MLA:
Sohn, Stefan, et al. "Cost of Moderate to Severe Plaque Psoriasis in Germany: A Multicenter Cost-of-Illness Study." Journal der Deutschen Dermatologischen Gesellschaft 212 (2006): 137-144.
BibTeX: Download